Breaking News Instant updates and real-time market news.

NBIX

Neurocrine

$76.64 /

-2.39 (-3.02%)

16:31
05/20/19
05/20
16:31
05/20/19
16:31

Neurocrine initiated with an Outperform at Credit Suisse

Credit Suisse analyst Evan Seigerman initiated Neurocrine with an Outperform rating and a $95 price target, calling the stock a Top Pick - SMID Cap. Seigerman believes Neurocrine's Ingrezza is "the best-in-class treatment" for tardive dyskinesia, or TD, and he expects it will drive revenue and earnings growth over the next few years. He also believes the company's pipeline has underappreciated upside potential, with assets for Parkinson's disease and congenital adrenal hyperplasia.

  • 22

    May

NBIX Neurocrine
$76.64 /

-2.39 (-3.02%)

05/14/19 Barclays
Myovant Sciences selloff overdone after report of relugolix data, says Barclays
04/29/19 Cantor Fitzgerald
Neurocrine selloff an opportunity for 'several reasons,' says Cantor Fitzgerald
04/26/19 Evercore ISI
Neurocrine shares defended at Evercore ISI
04/22/19 JPMorgan
JPMorgan upgrades Neurocrine to Overweight after 15% pullback

TODAY'S FREE FLY STORIES

Earnings
Verrica Pharmaceuticals reports Q2 EPS (38c), consensus (45c) » 07:19
08/05/20
08/05
07:19
08/05/20
07:19
VRCA

Verrica Pharmaceuticals

$6.43 /

-0.01 (-0.16%)

"We have made recent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

07/15/20 BofA
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA
06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

VRCA Verrica Pharmaceuticals
$6.43 /

-0.01 (-0.16%)

Recommendations
2021 could be 'big year' for Apple iPhones, says Bernstein » 07:19
08/05/20
08/05
07:19
08/05/20
07:19
AAPL

Apple

$438.80 /

+3.14 (+0.72%)

Bernstein analyst Toni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

06:19 Today BofA
BofA downgrades Apple to Neutral, ups price target to $470
06:09 Today BofA
Apple downgraded to Neutral from Buy at BofA
08/04/20 Susquehanna
Cirrus Logic price target raised to $86 from $78 at Susquehanna
07/31/20 Canaccord
Canaccord boosts Apple target to $460 after 'impressive' quarter
AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

AAPL Apple
$438.80 /

+3.14 (+0.72%)

Earnings
Ionis Pharmaceuticals reports Q2 EPS (23c), consensus (27c) » 07:19
08/05/20
08/05
07:19
08/05/20
07:19
IONS

Ionis Pharmaceuticals

$59.25 /

+0.02 (+0.03%)

Reports Q2 revenue $146M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$59.25 /

+0.02 (+0.03%)

IONS Ionis Pharmaceuticals
$59.25 /

+0.02 (+0.03%)

07/20/20 BMO Capital
Alnylam price target raised to $196 from $173 at BMO Capital
06/05/20 Citi
Ionis Pharmaceuticals price target raised to $80 from $71 at Citi
05/12/20 RBC Capital
Ionis Pharmaceuticals initiated with an Outperform at RBC Capital
04/22/20 Jefferies
Jefferies remains cautious on Ionis after report from partner Biogen
IONS Ionis Pharmaceuticals
$59.25 /

+0.02 (+0.03%)

IONS Ionis Pharmaceuticals
$59.25 /

+0.02 (+0.03%)

Earnings
Evergy sees FY20 adjusted EPS $2.90-$3.10, consensus $3.05  07:19
08/05/20
08/05
07:19
08/05/20
07:19
EVRG

Evergy

$55.45 /

-7.28 (-11.61%)

 
ShowHide Related Items >><<
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

08/03/20 Wolfe Research
Evergy downgraded to Peer Perform from Outperform at Wolfe Research
07/06/20 Wells Fargo
Evergy price target raised to $66 from $60 at Wells Fargo
06/03/20 Evercore ISI
Evergy upgraded to Outperform from In Line at Evercore ISI
03/03/20 BofA
Evergy upgraded to Buy from Underperform at BofA
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

Hot Stocks
Teva, Alvotech announce partnership to commercialize five biosimilar candidates » 07:18
08/05/20
08/05
07:18
08/05/20
07:18
TEVA

Teva

$11.80 /

-0.385 (-3.16%)

Teva and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TEVA Teva
$11.80 /

-0.385 (-3.16%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

07/27/20 Goldman Sachs
Teva initiated with a Neutral at Goldman Sachs
07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
TEVA Teva
$11.80 /

-0.385 (-3.16%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

TEVA Teva
$11.80 /

-0.385 (-3.16%)

Earnings
AmerisourceBergen reports Q3 adj. EPS $1.85, consensus $1.57 » 07:18
08/05/20
08/05
07:18
08/05/20
07:18
ABC

AmerisourceBergen

$104.86 /

+0.36 (+0.34%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
05/18/20 Argus
Argus sees long term growth opportunities for AmerisourceBergen
ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

ABC AmerisourceBergen
$104.86 /

+0.36 (+0.34%)

Earnings
CDW reports Q2 adj. EPS $1.56, consensus $1.38 » 07:18
08/05/20
08/05
07:18
08/05/20
07:18
CDW

CDW

$119.45 /

+1.86 (+1.58%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDW CDW
$119.45 /

+1.86 (+1.58%)

CDW CDW
$119.45 /

+1.86 (+1.58%)

06/29/20
Fly Intel: Top five analyst upgrades
06/29/20 Raymond James
CDW upgraded to Outperform from Market Perform at Raymond James
06/29/20 Raymond James
CDW upgraded to Outperform from Market Perform at Raymond James
06/09/20
Fly Intel: Top five analyst downgrades
CDW CDW
$119.45 /

+1.86 (+1.58%)

Earnings
Evergy reports Q2 adjusted EPS 68c, consensus 68c » 07:18
08/05/20
08/05
07:18
08/05/20
07:18
EVRG

Evergy

$55.45 /

-7.28 (-11.61%)

Evergy said second…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

08/03/20 Wolfe Research
Evergy downgraded to Peer Perform from Outperform at Wolfe Research
07/06/20 Wells Fargo
Evergy price target raised to $66 from $60 at Wells Fargo
06/03/20 Evercore ISI
Evergy upgraded to Outperform from In Line at Evercore ISI
03/03/20 BofA
Evergy upgraded to Buy from Underperform at BofA
EVRG Evergy
$55.45 /

-7.28 (-11.61%)

EVRG Evergy
$55.45 /

-7.28 (-11.61%)

Earnings
EVO Payments reports Q2 EPS (13c), consensus 0c » 07:17
08/05/20
08/05
07:17
08/05/20
07:17
EVOP

EVO Payments

$23.89 /

+0.3 (+1.27%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVOP EVO Payments
$23.89 /

+0.3 (+1.27%)

EVOP EVO Payments
$23.89 /

+0.3 (+1.27%)

07/14/20 Goldman Sachs
EVO Payments initiated with a Neutral at Goldman Sachs
06/05/20 Compass Point
EVO Payments price target raised to $22 from $16 at Compass Point
05/11/20 SunTrust
EVO Payments price target raised to $26 from $17 at SunTrust
05/11/20 Deutsche Bank
EVO Payments price target lowered to $29 from $33 at Deutsche Bank
EVOP EVO Payments
$23.89 /

+0.3 (+1.27%)

  • 05
    Dec
  • 13
    Aug
EVOP EVO Payments
$23.89 /

+0.3 (+1.27%)

Earnings
Chimera reports Q2 core EPS 32c, consensus 31c » 07:16
08/05/20
08/05
07:16
08/05/20
07:16
CIM

Chimera

$8.88 /

-0.075 (-0.84%)

Reports Q2 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CIM Chimera
$8.88 /

-0.075 (-0.84%)

CIM Chimera
$8.88 /

-0.075 (-0.84%)

05/18/20 RBC Capital
Chimera price target lowered to $11 from $23 at RBC Capital
10/02/19 RBC Capital
RBC Capital initiates select mortgage REITs with 'constructive' outlook
10/02/19 RBC Capital
Chimera initiated with an Outperform at RBC Capital
10/02/19 RBC Capital
Chimera initiated with an Outperform at RBC Capital
CIM Chimera
$8.88 /

-0.075 (-0.84%)

CIM Chimera
$8.88 /

-0.075 (-0.84%)

CIM Chimera
$8.88 /

-0.075 (-0.84%)

Earnings
Astec reports Q2 adj. EPS 67c, consensus 5c » 07:16
08/05/20
08/05
07:16
08/05/20
07:16
ASTE

Astec

$45.60 /

-0.62 (-1.34%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASTE Astec
$45.60 /

-0.62 (-1.34%)

ASTE Astec
$45.60 /

-0.62 (-1.34%)

04/23/20 Sidoti
Astec downgraded to Neutral with $41 price target at Sidoti
04/23/20 Sidoti
Astec downgraded to Neutral from Buy at Sidoti
04/01/20 Baird
Astec upgraded to Outperform at Baird
04/01/20 Baird
Astec upgraded to Outperform from Neutral at Baird
ASTE Astec
$45.60 /

-0.62 (-1.34%)

Hot Stocks
Domino's Pizza opens first store in Croatia » 07:15
08/05/20
08/05
07:15
08/05/20
07:15
DPZ

Domino's Pizza

$391.61 /

+4.46 (+1.15%)

Domino's Pizza is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

07/27/20 Stephens
McDonald's, Domino's among restaurant stocks to own now, says Stephens
07/22/20 Northcoast
Domino's Pizza not using aggressive discounts to drive growth, says Northcoast
07/17/20 MKM Partners
Domino's Pizza price target raised to $385 from $375 at MKM Partners
07/17/20 Deutsche Bank
Domino's Pizza price target raised to $404 from $333 at Deutsche Bank
DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

DPZ Domino's Pizza
$391.61 /

+4.46 (+1.15%)

Hot Stocks
Kinnevik announces support for proposed Teladoc Health and Livongo merger » 07:15
08/05/20
08/05
07:15
08/05/20
07:15
LVGO

Livongo Health

$144.48 /

+7.88 (+5.77%)

, TDOC

Teladoc

$249.11 /

+11.77 (+4.96%)

Kinnevik AB, which is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

07/30/20 Wells Fargo
Teladoc price target raised to $175 from $135 at Wells Fargo
07/30/20 Canaccord
Teladoc price target raised to $255 from $195 at Canaccord
07/30/20 JPMorgan
Teladoc price target raised to $266 from $240 at JPMorgan
07/30/20 Credit Suisse
Teladoc price target raised to $225 from $165 at Credit Suisse
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

  • 12
    Dec
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

Hot Stocks
Constellation Pharmaceuticals announces 2020 milestones » 07:15
08/05/20
08/05
07:15
08/05/20
07:15
CNST

Constellation Pharmaceuticals

$27.85 /

-0.58 (-2.04%)

The Company anticipates…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

06/24/20 JMP Securities
Constellation Pharmaceuticals initiated with a Market Perform at JMP Securities
06/12/20 RBC Capital
Constellation Pharmaceuticals data better than the prior cut, says RBC Capital
05/07/20 H.C. Wainwright
Constellation price target raised to $75 from $50 at H.C. Wainwright
03/11/20 BMO Capital
Constellation Pharmaceuticals price target lowered to $35 from $42 at BMO Capital
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

  • 17
    Jun
  • 11
    Dec
General news
FX Update: The dollar is down for a second day » 07:15
08/05/20
08/05
07:15
08/05/20
07:15

FX Update: The dollar is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Constellation expects cash to fund operations in mid-2023 » 07:15
08/05/20
08/05
07:15
08/05/20
07:15
CNST

Constellation Pharmaceuticals

$27.85 /

-0.58 (-2.04%)

Constellation expects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

06/24/20 JMP Securities
Constellation Pharmaceuticals initiated with a Market Perform at JMP Securities
06/12/20 RBC Capital
Constellation Pharmaceuticals data better than the prior cut, says RBC Capital
05/07/20 H.C. Wainwright
Constellation price target raised to $75 from $50 at H.C. Wainwright
03/11/20 BMO Capital
Constellation Pharmaceuticals price target lowered to $35 from $42 at BMO Capital
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

  • 17
    Jun
  • 11
    Dec
Earnings
BrainStorm reports Q2 EPS (25c), consensus (26c) » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
BCLI

BrainStorm

$13.33 /

-0.7 (-4.99%)

Cash, cash equivalents,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCLI BrainStorm
$13.33 /

-0.7 (-4.99%)

BCLI BrainStorm
$13.33 /

-0.7 (-4.99%)

07/08/20 Maxim
BrainStorm price target raised to $20 from $9 at Maxim
BCLI BrainStorm
$13.33 /

-0.7 (-4.99%)

BCLI BrainStorm
$13.33 /

-0.7 (-4.99%)

Hot Stocks
Adicet Bio receives $10M product development milestone from Regeneron » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
REGN

Regeneron

$647.09 /

+1.76 (+0.27%)

, TORC

resTORbio

$2.59 /

+0.035 (+1.37%)

Adicet Bio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

TORC resTORbio
$2.59 /

+0.035 (+1.37%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

08/04/20 Morgan Stanley
Regeneron preclinical antibody cocktail data 'encouraging,' says Morgan Stanley
07/20/20 Credit Suisse
Regeneron price target raised to $716 from $700 at Credit Suisse
07/09/20
Fly Intel: Top five analyst upgrades
07/08/20 SunTrust
Regeneron upgraded to Buy at SunTrust on Eylea resilience and pipeline
TORC resTORbio
$2.59 /

+0.035 (+1.37%)

04/29/20 Evercore ISI
resTORbio upgraded to Outperform from In Line at Evercore ISI
11/15/19 Wedbush
resTORbio downgraded to Neutral from Outperform at Wedbush
11/15/19 Guggenheim
resTORbio downgraded to Neutral from Buy at Guggenheim
11/15/19 Cantor Fitzgerald
resTORbio downgraded to Neutral from Overweight at Cantor Fitzgerald
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

TORC resTORbio
$2.59 /

+0.035 (+1.37%)

  • 27
    May
REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

REGN Regeneron
$647.09 /

+1.76 (+0.27%)

Earnings
Rocket Pharmaceuticals reports Q2 EPS (45c), consensus (51c) » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
RCKT

Rocket Pharmaceuticals

$24.87 /

+0.07 (+0.28%)

"During this…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCKT Rocket Pharmaceuticals
$24.87 /

+0.07 (+0.28%)

RCKT Rocket Pharmaceuticals
$24.87 /

+0.07 (+0.28%)

07/21/20 Piper Sandler
Rocket shares should be owned through year-end, says Piper Sandler
07/02/20 JPMorgan
Rocket Pharmaceuticals initiated with an Overweight at JPMorgan
06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
RCKT Rocket Pharmaceuticals
$24.87 /

+0.07 (+0.28%)

  • 11
    Dec
Earnings
Constellation Pharmaceuticals reports Q1 EPS (70c), consensus (63c) » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
CNST

Constellation Pharmaceuticals

$27.85 /

-0.58 (-2.04%)

"Having seen signals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

06/24/20 JMP Securities
Constellation Pharmaceuticals initiated with a Market Perform at JMP Securities
06/12/20 RBC Capital
Constellation Pharmaceuticals data better than the prior cut, says RBC Capital
05/07/20 H.C. Wainwright
Constellation price target raised to $75 from $50 at H.C. Wainwright
03/11/20 BMO Capital
Constellation Pharmaceuticals price target lowered to $35 from $42 at BMO Capital
CNST Constellation Pharmaceuticals
$27.85 /

-0.58 (-2.04%)

  • 17
    Jun
  • 11
    Dec
Earnings
Nexstar reports Q2 EPS $2.13, consensus $1.18 » 07:14
08/05/20
08/05
07:14
08/05/20
07:14
NXST

Nexstar

$89.45 /

+0.7 (+0.79%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NXST Nexstar
$89.45 /

+0.7 (+0.79%)

NXST Nexstar
$89.45 /

+0.7 (+0.79%)

06/22/20 Benchmark
Nexstar price target raised to $125 from $120 at Benchmark
05/07/20 Wells Fargo
Nexstar price target raised to $88 from $81 at Wells Fargo
05/07/20 B. Riley FBR
Nexstar price target raised to $115 from $110 at B. Riley FBR
05/05/20 B. Riley FBR
Nexstar price target lowered to $110 from $139 at B. Riley FBR
NXST Nexstar
$89.45 /

+0.7 (+0.79%)

Earnings
GasLog reports Q2 EPS 3c, consensus 0c » 07:13
08/05/20
08/05
07:13
08/05/20
07:13
GLOG

GasLog

$3.16 /

+0.145 (+4.81%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLOG GasLog
$3.16 /

+0.145 (+4.81%)

GLOG GasLog
$3.16 /

+0.145 (+4.81%)

06/23/20 Fearnley
GasLog downgraded to Hold from Buy at Fearnley
06/02/20 Pareto
GasLog downgraded to Sell from Hold at Pareto
03/31/20 Pareto
GasLog upgraded to Hold from Sell at Pareto
03/09/20 DNB Markets
GasLog downgraded to Hold from Buy at DNB Markets
GLOG GasLog
$3.16 /

+0.145 (+4.81%)

Earnings
Charles River raises FY20 adj. EPS view to $7.05-$7.35 from $6.75-$7.10 » 07:13
08/05/20
08/05
07:13
08/05/20
07:13
CRL

Charles River

$203.78 /

-3.69 (-1.78%)

Consensus $6.91. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRL Charles River
$203.78 /

-3.69 (-1.78%)

CRL Charles River
$203.78 /

-3.69 (-1.78%)

07/21/20 UBS
Charles River price target raised to $236 from $200 at UBS
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
07/01/20 BofA
Charles River upgraded to Buy from Neutral at BofA
05/26/20 Argus
Charles River price target raised to $190 from $150 at Argus
CRL Charles River
$203.78 /

-3.69 (-1.78%)

Hot Stocks
Bausch Health resolves Canadian securities class action » 07:13
08/05/20
08/05
07:13
08/05/20
07:13
BHC

Bausch Health

$18.99 /

-0.13 (-0.68%)

Bausch Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

06/17/20 H.C. Wainwright
Bausch Health price target raised to $64 from $50 at H.C. Wainwright
06/03/20 Jefferies
Duobrii could become a key revenue driver for Bausch Health, says Jefferies
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Bausch Health initiated with a Buy at Citi
BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

BHC Bausch Health
$18.99 /

-0.13 (-0.68%)

Earnings
Starwood Property reports Q2 core EPS 43c, consensus 42c » 07:12
08/05/20
08/05
07:12
08/05/20
07:12
STWD

Starwood Property

$14.93 /

+0.03 (+0.20%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

05/05/20 B. Riley FBR
Starwood Property price target lowered to $18 from $27 at B. Riley FBR
04/27/20 Credit Suisse
Starwood Property price target lowered to $16 from $26 at Credit Suisse
12/02/19 Wells Fargo
Starwood Property initiated with an Outperform at Wells Fargo
08/14/19 Raymond James
Starwood Property price target raised to $27 from $24 at Raymond James
STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

STWD Starwood Property
$14.93 /

+0.03 (+0.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.